Virtual Summit: Bionconjugates

The NEW Virtual Summits are one-day virtual programs on different hot topics with four sessions of speaker presentations and panel discussions.

This Virtual Summit on "Tackling Bioconjugate Challenges" aims to discuss two key challenges faced by bioconjugate developers and manufacturers: impurity control strategies and comparability assessments. The first part of the Summit will explore different approaches and control strategies for ensuring product quality while safeguarding patient safety. Attendees will also explore the risk-based assessments and enhanced process understanding that could be used to guide the strategy for comparability determinations. The Summit will share case studies for these complex challenges. Both topics will also have panel discussions with industry and regulatory experts to further discuss the considerations needed to ensure patient safety and therapeutic benefit. 

For more information about the Summit on Bionconjugates, contact Kellie Greene-Bailey.

For more information about the Summit on Manufacturing, contact Kellie Greene-Bailey.